IMARC Group’s report titled “Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033”. The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033.
Factors Affecting the Growth of the Coronary Stents Industry:
- Increasing Prevalence of Cardiovascular Diseases:
As more people are suffering from cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), the number of required medical interventions, including angioplasty and stenting, is naturally increasing. Coronary stents are crucial in these procedures to keep arteries open and ensure blood flow to the heart, thus directly correlating the prevalence of CVDs with the demand for stents. Moreover, the rise in heart disease is leading to a stronger focus on preventive cardiology, which aims to address the disease before severe interventions are needed. However, for many individuals, stenting is becoming a necessary preventive measure to avoid more severe outcomes like heart attacks.
- Technological Advancements:
Drug-eluting stents are significantly improving outcomes for patients undergoing coronary interventions. These stents release medication directly into the artery wall to prevent the artery from becoming blocked again, which is a common issue with bare-metal stents. The continued evolution in the types of drugs used and the delivery mechanisms directly impact market growth by offering more effective solutions that reduce the need for repeat procedures. Furthermore, advancements in materials science are leading to the development of more flexible stents that conform better to the natural shape of blood vessels and are less prone to fracture. These improvements make the stents safer and more effective, thereby increasing their acceptance among cardiologists and patients.
- Growing Aging Population:
As people are aging, the risk of developing cardiovascular conditions, such as coronary artery disease, is increasing due to factors like the natural aging of the vascular system and increased prevalence of risk factors, such as hypertension, diabetes, and high cholesterol. Since coronary stents are a key treatment option for managing these diseases, an aging population is directly catalyzing the demand for these devices. In addition, older adults typically require more medical care, including more frequent and intensive cardiovascular treatments. This demographic tends to use a higher volume of healthcare services, including angioplasty, where stents are used, thus driving up market demand.
Grab a sample PDF of this report: https://www.imarcgroup.com/coronary-stents-market/requestsample
Leading Companies Operating in the Global Coronary Stents Industry:
- Abbott Laboratories
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical Corporation
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Terumo Corporation
- Translumina GmbH.
Coronary Stents Market Report Segmentation:
By Type:
- Drug-eluting Stents
- Bare-metal Coronary Stents
- Bioabsorbable Stents
Drug-eluting stents represent the largest segment due to their superior clinical outcomes compared to other types of stents.
By Biomaterial:
- Metallic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
Metallic biomaterial accounts for the majority of the market share owing to its exceptional mechanical properties, biocompatibility, and proven clinical efficacy.
By Mode of Delivery:
- Balloon-expandable Stents
- Self-expanding Stents
Self-expanding stents hold the biggest market share as their flexibility and ability to conform to the natural contours of the blood vessels make them particularly effective in treating complex lesions and tortuous anatomies.
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Hospitals exhibit a clear dominance in the market, driven by comprehensive care provided by them, including preoperative, perioperative, and postoperative management.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the coronary stents market on account of a high prevalence of cardiovascular diseases.
Global Coronary Stents Market Trends:
Enhancements in imaging technologies, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow for better placement and assessment of stents, ensuring that procedures are more successful and reducing complications. This technological synergy not only expands the effectiveness of stents but also drives their adoption by providing more confidence in procedural outcomes.
In addition, the integration of coronary stents with digital health technologies, including remote monitoring and real-time data analytics, enhances patient management post-implantation. This integration helps in monitoring stent performance and patient health, potentially alerting healthcare providers to issues before they become severe, thereby improving long-term outcomes.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145